Melbourne scientists develop cows’ milk that protects against HIV
26 October 2012 | By F T I Consulting
Melbourne researchers have developed cows’ milk that can protect human cells from human immunodeficiency virus (HIV)...
List view / Grid view
News
The Respimat® success story
26 October 2012 | By Boehringer Ingelheim
Successful treatment of respiratory diseases also depends on how much of the active substance enters the patient's lung...
Daiichi Sankyo completes enrolment in Hokusai-VTE
25 October 2012 | By Daiichi Sankyo
Edoxaban is an investigational, once daily, novel oral factor Xa inhibitor...
Novartis confident in safety and efficacy of its seasonal influenza vaccines produced in Italy
25 October 2012 | By Novartis
Confidence in the safety and efficacy of seasonal influenza vaccines...
FDA discloses focus of Advisory Committee meeting on insulin degludec and insulin degludec/insulin aspart
25 October 2012 | By Novo Nordisk
“This meeting will focus on the cardiovascular safety of two products..."
The British Laboratory Managers Association to launch at LAB INNOVATIONS
24 October 2012 | By Energy PR
The British Laboratory Managers Association is being launched by GAMBICA...
Abbott’s ALK test is now available in Europe as a companion diagnostic test to aid in identifying patients for targeted lung cancer therapy
24 October 2012 | By Abbott
ALK test now available in Europe...
Pfizer’s XALKORI® receives conditional marketing authorization from the European Commission
24 October 2012 | By Pfizer
Conditional marketing authorization for XALKORI® in the EU granted...
Abbott announces data evaluating reduction of steroid usage with HUMIRA® (Adalimumab)
24 October 2012 | By Abbott
"These data suggest that adalimumab-treated patients were able to reduce steroid usage..."
Results from new Phase III study amongst women for corifollitropin alfa, an investigational fertility treatment for controlled ovarian stimulation
23 October 2012 | By Merck
New Phase III study presented...
Abbott announces new data evaluating mucosal healing with HUMIRA® (Adalimumab)
23 October 2012 | By Abbott
Results from a post-hoc sub-analysis...
AstraZeneca and Ironwood announce linaclotide collaboration for China
23 October 2012 | By AstraZeneca
AstraZeneca and Ironwood Pharmaceuticals, Inc. announced an agreement to co-develop and co-commercialise Ironwood’s linaclotide...
Rapid, high throughput preformulation with Avacta’s Optim® 1000
23 October 2012 | By kdm communications limited
Avacta Analytical’s Optim® 1000 is proving a valuable asset to scientists at the MVSC, University of Kansas, USA...
Lonza and OncoMed Pharmaceuticals sign a process development and manufacturing collaboration and multi-product GS license agreement
Lonza, a global leader in biological manufacturing and OncoMed Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to improving cancer treatment, announced today an agreement for the development and manufacture of OncoMed’s pipeline of anti-cancer stem cell therapeutics.
Abbott announces three-year long-term data evaluating efficacy with HUMIRA® (Adalimumab)
22 October 2012 | By Abbott
Results from an analysis of three-year long-term data...
